Literature DB >> 23622515

A Cdk7-Cdk4 T-loop phosphorylation cascade promotes G1 progression.

Miriam Merzel Schachter1, Karl A Merrick, Stéphane Larochelle, Alexander Hirschi, Chao Zhang, Kevan M Shokat, Seth M Rubin, Robert P Fisher.   

Abstract

Eukaryotic cell division is controlled by cyclin-dependent kinases (CDKs), which require phosphorylation by a CDK-activating kinase (CAK) for full activity. Chemical genetics uncovered requirements for the metazoan CAK Cdk7 in determining cyclin specificity and activation order of Cdk2 and Cdk1 during S and G2 phases. It was unknown if Cdk7 also activates Cdk4 and Cdk6 to promote passage of the restriction (R) point, when continued cell-cycle progression becomes mitogen independent, or if CDK-activating phosphorylation regulates G1 progression. Here we show that Cdk7 is a Cdk4- and Cdk6-activating kinase in human cells, required to maintain activity, not just to establish the active state, as is the case for Cdk1 and Cdk2. Activating phosphorylation of Cdk7 rises concurrently with that of Cdk4 as cells exit quiescence and accelerates Cdk4 activation in vitro. Therefore, mitogen signaling drives a CDK-activation cascade during G1 progression, and CAK might be rate-limiting for R point passage.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23622515      PMCID: PMC3677717          DOI: 10.1016/j.molcel.2013.04.003

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  49 in total

1.  Dephosphorylation of human cyclin-dependent kinases by protein phosphatase type 2C alpha and beta 2 isoforms.

Authors:  A Cheng; P Kaldis; M J Solomon
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

2.  T-loop phosphorylation stabilizes the CDK7-cyclin H-MAT1 complex in vivo and regulates its CTD kinase activity.

Authors:  S Larochelle; J Chen; R Knights; J Pandur; P Morcillo; H Erdjument-Bromage; P Tempst; B Suter; R P Fisher
Journal:  EMBO J       Date:  2001-07-16       Impact factor: 11.598

3.  Crystal structure of human CDK4 in complex with a D-type cyclin.

Authors:  Philip J Day; Anne Cleasby; Ian J Tickle; Marc O'Reilly; Joe E Coyle; Finn P Holding; Rachel L McMenamin; Jeff Yon; Rajiv Chopra; Christoph Lengauer; Harren Jhoti
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

4.  Phosphorylation-induced conformational changes in the retinoblastoma protein inhibit E2F transactivation domain binding.

Authors:  Jason R Burke; Alison J Deshong; Jeffrey G Pelton; Seth M Rubin
Journal:  J Biol Chem       Date:  2010-03-11       Impact factor: 5.157

5.  Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop.

Authors:  S Garrett; W A Barton; R Knights; P Jin; D O Morgan; R P Fisher
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

6.  The structure of CDK4/cyclin D3 has implications for models of CDK activation.

Authors:  T Takaki; A Echalier; N R Brown; T Hunt; J A Endicott; M E M Noble
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

7.  Genetic inactivation of Cdk7 leads to cell cycle arrest and induces premature aging due to adult stem cell exhaustion.

Authors:  Miguel Ganuza; Cristina Sáiz-Ladera; Marta Cañamero; Gonzalo Gómez; Ralph Schneider; María A Blasco; David Pisano; Jesús M Paramio; David Santamaría; Mariano Barbacid
Journal:  EMBO J       Date:  2012-04-13       Impact factor: 11.598

8.  Switching Cdk2 on or off with small molecules to reveal requirements in human cell proliferation.

Authors:  Karl A Merrick; Lara Wohlbold; Chao Zhang; Jasmina J Allen; Dai Horiuchi; Noelle E Huskey; Andrei Goga; Kevan M Shokat; Robert P Fisher
Journal:  Mol Cell       Date:  2011-06-10       Impact factor: 17.970

9.  CDK8 is a positive regulator of transcriptional elongation within the serum response network.

Authors:  Aaron J Donner; Christopher C Ebmeier; Dylan J Taatjes; Joaquín M Espinosa
Journal:  Nat Struct Mol Biol       Date:  2010-01-24       Impact factor: 15.369

10.  Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II.

Authors:  Stéphane Larochelle; Ramon Amat; Kira Glover-Cutter; Miriam Sansó; Chao Zhang; Jasmina J Allen; Kevan M Shokat; David L Bentley; Robert P Fisher
Journal:  Nat Struct Mol Biol       Date:  2012-10-14       Impact factor: 15.369

View more
  49 in total

Review 1.  Pause, play, repeat: CDKs push RNAP II's buttons.

Authors:  Miriam Sansó; Robert P Fisher
Journal:  Transcription       Date:  2013-06-11

2.  Cyclin-dependent kinase 7 controls mRNA synthesis by affecting stability of preinitiation complexes, leading to altered gene expression, cell cycle progression, and survival of tumor cells.

Authors:  Timothy W R Kelso; Karen Baumgart; Jan Eickhoff; Thomas Albert; Claudia Antrecht; Sarah Lemcke; Bert Klebl; Michael Meisterernst
Journal:  Mol Cell Biol       Date:  2014-07-21       Impact factor: 4.272

Review 3.  The Temporal Regulation of S Phase Proteins During G1.

Authors:  Gavin D Grant; Jeanette G Cook
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

4.  Development of a Selective CDK7 Covalent Inhibitor Reveals Predominant Cell-Cycle Phenotype.

Authors:  Calla M Olson; Yanke Liang; Alan Leggett; Woojun D Park; Lianbo Li; Caitlin E Mills; Selma Z Elsarrag; Scott B Ficarro; Tinghu Zhang; Robert Düster; Matthias Geyer; Taebo Sim; Jarrod A Marto; Peter K Sorger; Ken D Westover; Charles Y Lin; Nicholas Kwiatkowski; Nathanael S Gray
Journal:  Cell Chem Biol       Date:  2019-03-21       Impact factor: 8.116

5.  ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment.

Authors:  Hetal Patel; Manikandan Periyasamy; Georgina P Sava; Alexander Bondke; Brian W Slafer; Sebastian H B Kroll; Marion Barbazanges; Richard Starkey; Silvia Ottaviani; Alison Harrod; Eric O Aboagye; Laki Buluwela; Matthew J Fuchter; Anthony G M Barrett; R Charles Coombes; Simak Ali
Journal:  Mol Cancer Ther       Date:  2018-03-15       Impact factor: 6.261

6.  The CDK4/CDK6 inhibitor PD0332991 paradoxically stabilizes activated cyclin D3-CDK4/6 complexes.

Authors:  Sabine Paternot; Bianca Colleoni; Xavier Bisteau; Pierre P Roger
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

7.  Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional Repression.

Authors:  Maria Rusan; Kapsok Li; Yvonne Li; Camilla L Christensen; Brian J Abraham; Nicholas Kwiatkowski; Kevin A Buczkowski; Bruno Bockorny; Ting Chen; Shuai Li; Kevin Rhee; Haikuo Zhang; Wankun Chen; Hideki Terai; Tiffany Tavares; Alan L Leggett; Tianxia Li; Yichen Wang; Tinghu Zhang; Tae-Jung Kim; Sook-Hee Hong; Neermala Poudel-Neupane; Michael Silkes; Tenny Mudianto; Li Tan; Takeshi Shimamura; Matthew Meyerson; Adam J Bass; Hideo Watanabe; Nathanael S Gray; Richard A Young; Kwok-Kin Wong; Peter S Hammerman
Journal:  Cancer Discov       Date:  2017-10-20       Impact factor: 39.397

8.  CDK7 Inhibition Potentiates Genome Instability Triggering Anti-tumor Immunity in Small Cell Lung Cancer.

Authors:  Hua Zhang; Camilla L Christensen; Ruben Dries; Matthew G Oser; Jiehui Deng; Brian Diskin; Fei Li; Yuanwang Pan; Xuzhu Zhang; Yandong Yin; Eleni Papadopoulos; Val Pyon; Cassandra Thakurdin; Nicholas Kwiatkowski; Kandarp Jani; Alexandra R Rabin; Dayanne M Castro; Ting Chen; Heather Silver; Qingyuan Huang; Mirna Bulatovic; Catríona M Dowling; Belen Sundberg; Alan Leggett; Michela Ranieri; Han Han; Shuai Li; Annan Yang; Kristen E Labbe; Christina Almonte; Vladislav O Sviderskiy; Max Quinn; Jack Donaghue; Eric S Wang; Tinghu Zhang; Zhixiang He; Vamsidhar Velcheti; Peter S Hammerman; Gordon J Freeman; Richard Bonneau; William G Kaelin; Kate D Sutherland; Ariena Kersbergen; Andrew J Aguirre; Guo-Cheng Yuan; Eli Rothenberg; George Miller; Nathanael S Gray; Kwok-Kin Wong
Journal:  Cancer Cell       Date:  2019-12-26       Impact factor: 31.743

9.  Activation of the p53 Transcriptional Program Sensitizes Cancer Cells to Cdk7 Inhibitors.

Authors:  Sampada Kalan; Ramon Amat; Miriam Merzel Schachter; Nicholas Kwiatkowski; Brian J Abraham; Yanke Liang; Tinghu Zhang; Calla M Olson; Stéphane Larochelle; Richard A Young; Nathanael S Gray; Robert P Fisher
Journal:  Cell Rep       Date:  2017-10-10       Impact factor: 9.423

10.  An integrative multi-omics approach uncovers the regulatory role of CDK7 and CDK4 in autophagy activation induced by silica nanoparticles.

Authors:  Chen Ruan; Chenwei Wang; Xuanqing Gong; Ying Zhang; Wankun Deng; Jiaqi Zhou; Dengtong Huang; Zining Wang; Qiong Zhang; Anyuan Guo; Jiahong Lu; Jinhao Gao; Di Peng; Yu Xue
Journal:  Autophagy       Date:  2020-05-23       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.